Items where authors include "Riley, M."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Palmer, A.K. orcid.org/0000-0003-4789-1464, Riley, M. orcid.org/0000-0002-3259-323X, Clement, S. orcid.org/0000-0002-5422-622X et al. (4 more authors) (2025) In and out of place: Diverse experiences and perceived exclusion in UK greenspace settings. Environment and Planning E: Nature and Space. ISSN 2514-8486

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Palmer, A.K. orcid.org/0000-0003-4789-1464, Riley, M. orcid.org/0000-0002-3259-323X, Brockett, B.F.T. orcid.org/0000-0003-3065-0437 et al. (3 more authors) (2023) Towards an understanding of quality and inclusivity in human‐environment experiences. Geography Compass, 17 (10). e12723. ISSN 1749-8198

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736